MDI-1228-mesylate Gel

MDI-1228 mesylate gel · Zhuhai Rui-Inno Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MDI-1228-mesylate Gel, covering 2025-03-07 to 2025-03-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers [Phase 2]

See pricing